EVERSANA Expands AI-Powered Commercialization Platform to Transform Life Sciences Operations21. August 2026
News Caristo Diagnostics Receives FDA De Novo Authorization for CaRi-Heart AI PlatformHealthradar30. Juli 2026 What You Should Know Oxford spin-out Caristo Diagnostics has secured FDA De Novo authorization for CaRi-Heart®, making it the first…